Insulin Syringes (U-100, 0.3 mL or 0.5 mL) One syringe per daily pre-blended injection
GLP-1 microdosing: Breaking down the basics Traditional GLP-1 protocols often follow a standardized escalation model
When large meals or high-fat foods are consumed, patients may experience increased nausea, bloating, abdominal discomfort, or even vomiting
Your provider should assess individual risk-benefit profiles before initiating treatment
Exendin-4 (an endogenous insulin releasing incretin, GLP-1) reduces A accumulation and tau hyperphosphorylation in cellular and animal models of AD (151, 153156)
Pregnant or breastfeeding women, as the safety of Ozempic during pregnancy has not been established